Proteomics methods and applications for the practicing clinician

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 6, 2009, Pages 523-529

  Reisdorph, Nichole A ^a   Reisdorph, Richard ^a   Bowler, Russell ^a   Broccardo, Carolyn ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALLERGY; ASTHMA; ATOPIC DERMATITIS; BIOINFORMATICS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; LIQUID CHROMATOGRAPHY; LUNG DISEASE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 67549091528     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60128-7     Document Type: Article

References (47)

1. Hanash S. Disease proteomics. Nature. 2003;422:226-232. (Pubitemid 36362760)
2. Granger CB, Van Eyk JE, Mockrin SC, Anderson NL. National heart, lung, and blood institute clinical proteomics working group report. Circulation. 2004;109:1697-1703. (Pubitemid 38500667)
3. Wattiez R, Falmagne P. Proteomics of bronchoalveolar lavage fluid. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;815:169-178. (Pubitemid 40126399)
4. Magi B, Bargagli E, Bini L, Rottoli P. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics. 2006;6:6354-6369. (Pubitemid 44935519)
5. Gray RD, MacGregor G, Noble D, et al. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med. 2008;178:444-452.
6. Nicholas B, Skipp P, Mould R, et al. Shotgun proteomic analysis of human-induced sputum. Proteomics. 2006;6:4390-4401. (Pubitemid 44277040)
7. Mischak HA, Banks RE, Conaway M, et al. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl. 2007;1:148-156.
8. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature. 2003;422:198-207. (Pubitemid 36362757)
9. Bowler RP, Ellison MC, Reisdorph N. Proteomics in pulmonary medicine. Chest. 2006;130:567-574. (Pubitemid 44267028)
10. Lescuyer P, Hochstrasser D, Rabilloud T. How shall we use the proteomics toolbox for biomarker discovery? J Proteome Res. 2007;6:3371-3376. (Pubitemid 47522726)
11. Good DM, Thongboonkerd V, Novak J, et al. Body fluid proteomics for biomarker discovery: Lessons from the past hold the key to success in the future. J Proteome Res. 2007;6:4549-4555.
12. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002;1:845-867.
13. Hoffman SA, Joo WA, Echan LA, Speicher DW. Higher dimensional (hi-d) separation strategies dramatically improve the potential for cancer biomarker detection in serum and plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;849:43-52. (Pubitemid 46529317)
14. Wu J, Kobayashi M, Sousa EA, et al. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics. 2005;4:1251-1264. (Pubitemid 41448713)
15. Ogata Y, Charlesworth MC, Higgins L, et al. Differential protein expression in male and female human lumbar cerebrospinal fluid using ITRAQ reagents after abundant protein depletion. Proteomics. 2007;7:3726-3734. (Pubitemid 350022278)
16. Drake RR, Schwegler EE, Malik G, et al. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics. 2006;5:1957-1967. (Pubitemid 44688203)
17. Benson LM, Mason CJ, Friedman O, et al. Extensive fractionation and identification of proteins within nasal lavage fluids from allergic rhinitis and asthmatic chronic rhinosinusitis patients. J Sep Sci. 2009;32:44-56.
18. Yeo S, Roh GS, Kim DH, et al. Quantitative profiling of plasma peptides in asthmatic mice using liquid chromatography and mass spectrometry. Proteomics. 2004;4:3308-3317. (Pubitemid 39525278)
19. Righetti PG, Castagna A, Herbert B, Candiano G. How to bring the "unseen" proteome to the limelight via electrophoretic pre-fractionation techniques. Biosci Rep. 2005;25:3-17. (Pubitemid 41437706)
20. Magi B, Bini L, Perari MG, et al. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis. 2002;23:3434-3444. (Pubitemid 35230229)
21. Current Protocols in Protein Science. Maltham, MA: John Wiley & Sons Inc; 2008.
22. Old WM, Meyer-Arendt K, Aveline-Wolf L, et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics. 2005;4:1487-1502. (Pubitemid 41555475)
23. Wu WW, Wang G, Baek SJ, Shen RF. Comparative study of three proteomic quantitative methods, DIGE, CICAT, and ITRAQ, using 2D gel- or LC-MALDI TOF/TOF. J Proteome Res. 2006;5:651-658. (Pubitemid 43364106)
24. Gulcicek EE, Colangelo CM, McMurray W, et al. Proteomics and the analysis of proteomic data: an overview of current protein-profiling technologies. Curr Protoc Bioinformatics. 2005;chap 13, unit 13 11.
25. Cornett DS, Reyzer ML, Chaurand P, Caprioli RM. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat Methods. 2007;4:828-833. (Pubitemid 350055580)
26. Groseclose MR, Massion PP, Chaurand P, Caprioli RM. Highthroughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics. 2008;8:3715-3724.
27. Massion PP, Caprioli RM. Proteomic strategies for the characterization and the early detection of lung cancer. J Thorac Oncol. 2006;1:1027-1039. (Pubitemid 47181375)
28. Deutsch EW, Lam H, Aebersold R. Data analysis and bioinformatics tools for tandem mass spectrometry in proteomics. Physiol Genomics. 2008;33:18-25.
29. Hirsch J, Hansen KC, Burlingame AL, Matthay MA. Proteomics: current techniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol. 2004;287:L1-23. (Pubitemid 38787645)
30. Greenlee KJ, Corry DB, Engler DA, et al. Proteomic identification of in vivo substrates for matrix metalloproteinases 2 and 9 reveals a mechanism for resolution of inflammation. J Immunol. 2006;177:7312-7321. (Pubitemid 44715101)
31. Halapi E, Hakonarson H. Recent development in genomic and proteomic research for asthma. Curr Opin Pulm Med. 2004;10:22-30. (Pubitemid 38045897)
32. Howell MD, Fairchild HR, Kim BE, et al. Th2 cytokines act on s100/a11 to downregulate keratinocyte differentiation. J Invest Dermatol. 2008;128:2248-2258.
33. Roh GS, Shin Y, Seo SW, et al. Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics. 2004;4:3318-3327. (Pubitemid 39525279)
34. Sepper R, Prikk K. Proteomics: is it an approach to understand the progression of chronic lung disorders? J Proteome Res. 2004;3:277-281. (Pubitemid 38500995)
35. Wong WS, Zhu H, Liao W. Cysteinyl leukotriene receptor antagonist mk-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model. Eur J Pharmacol. 2007;575:134-141. (Pubitemid 47576058)
36. Wong WS, Zhao J. Proteome analysis of chronically inflamed lungs in a mouse chronic asthma model. Int Arch Allergy Immunol. 2008;147:179-189.
37. Bowler RP, Canham ME, Ellison MC. Surface enhanced laser desorption/ionization (SELDI) time-of-flight mass spectrometry to identify patients with chronic obstructive pulmonary disease. COPD. 2006;3:41-50. (Pubitemid 43869515)
38. Das S, Maeso PA, Becker AM, et al. Proteomics blood testing to distinguish chronic rhinosinusitis subtypes. Laryngoscope. 2008;118:2231-2234.
39. Baldini C, Giusti L, Bazzichi L, Lucacchini A, Bombardieri S. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjogren's syndrome? Autoimmun Rev. 2008;7:185-191.
40. Kiehntopf M, Siegmund R, Deufel T. Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations. Clin Chem Lab Med. 2007;45:1435-1449. (Pubitemid 350036581)
41. Akagawa M, Handoyo T, Ishii T, et al. Proteomic analysis of wheat flour allergens. J Agric Food Chem. 2007;55:6863-6870. (Pubitemid 47338919)
42. Batista R, Martins I, Jeno P, Ricardo CP, Oliveira MM. A proteomic study to identify soya allergens: the human response to transgenic versus nontransgenic soya samples. Int Arch Allergy Immunol. 2007;144:29-38. (Pubitemid 47237666)
43. Chassaigne H, Norgaard JV, Hengel AJ. Proteomics-based approach to detect and identify major allergens in processed peanuts by capillary LC-Q-TOF (MS/MS). J Agric Food Chem. 2007;55:4461-4473. (Pubitemid 46932643)
44. Benndorf D, Muller A, Bock K, et al. Identification of spore allergens from the indoor mould aspergillus versicolor. Allergy. 2008;63:454-460. (Pubitemid 351341819)
45. Cao L, Yu K, Banh C, et al. Quantitative time-resolved phosphoproteomic analysis of mast cell signaling. J Immunol. 2007;179:5864-5876.
46. Wilcken B, Wiley V. Newborn screening. Pathology. 2008;40:104-115.
47. Serkova N, Reisdorph N, Tissot van Patot M. Metabolic markers of hypoxia: systems biology application in biomedicine. Toxicol Mechanisms Methods. 2007;18:81-95.